6505-01-275-6048 ( NDC50474-0300-50 , NDC50111-0459-02 , NDC50474-2852-08 , NDC50111-0459-02 )

NSN Information
NSN FSC NIIN Item Name INC
6505-01-275-6048 6505 012756048 THEOPHYLLINE EXTENDED-RELEASE CA 4277
NSN Features
MRC Parameter Characteristics
CQLS CAPSULE CONTENT FORM ANY ACCEPTABLE
AKJA ACTIVE MEDICAMENT MEDICINAL STRENGTH 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CXCY PART NAME ASSIGNED BY CONTROLLING AGENCY THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 500S BT
CQCT PRIMARY CONTAINER TYPE BOTTLE
CYLZ CAPSULE PRIMARY CONTAINER CONTENT QUANTITY 500.000
AKJC CAPSULE TYPE ANY ACCEPTABLE
THPE THERAPEUTIC EQUIVALENT TO THEO-24 CR CAPSULES BY SEARLE LABORATORIES
FEAT SPECIAL FEATURES ANHYDROUS
Manufacturing Part Numbers (SKUs)
Part SKU Cage Status RNVC RNCC SADC DAC RNAAC
NDC50474-0300-50 66911 A 2 3 4 ZZ
NDC50111-0459-02 1BL76 A 2 3 4 ZZ
NDC50474-2852-08 096R2 A 9 5 4 ZZ
NDC50111-0459-02 096R2 A 2 3 4 ZZ
Manufacturers
Part SKU Cage Manufacturer Type Status
NDC50474-0300-50 66911 RUSS PHARMACEUTICALS INC A A
NDC50111-0459-02 1BL76 SIDMAK LABORATORIES INC F A
NDC50474-2852-08 096R2 WHITBY PHARMACEUTICALS INC F A
NDC50111-0459-02 096R2 WHITBY PHARMACEUTICALS INC F A
FLIS Identification
PMIC ADPE Code CRITL Code DEMIL Code DEMIL INTG NIIN Asgt ESD HMIC ENAC Schedule-B INC
A X A 1 03/23/1 P 3004909185 4277
FLIS Management
MOE REC Rep Code Mgmt Ctl USC Phrase Code Phrase Statement
DA C2201X- A K U/I CONTAINS 500 EA
DS I K U/I CONTAINS 500 EA
DN 9B----- N K U/I CONTAINS 500 EA
DF ------- F K U/I CONTAINS 500 EA
Demilitarization Codes & Management
DML PMI HMIC ADP CC ESDC
A A P X
Miscellaneous Management
MOE (S_A) SOS AAC QUP UI SLC CIIC RC MCC SVC
DS SMS L 1 BT K U D
DF SMS L 1 BT K U ------- F
DN SMS L 1 BT K U 9B----- N
DA SMS L 1 BT K U C2201X- A
Management Control Army
MATCAT 1 MATCAT 2 MATCAT 3 MATCAT 4 5 ARC
C 2 2 01 X
Freight
NMFC NMFC SUB UFC HMC LTL LCL WCC TCC SHC ADC ACC ASH NMF DESC